drugset / Trial / NCT06276205

Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism

NCT06276205

Phase 3 Completed 62 enrolled King Edward Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to study the improvement of lipid levels in hypothyroid individuals after staring treatment. The main question it aims to answer is: • whether adding Vitamin D to standard therapy has any additional benefits Participants will be given Vitamin D in replacement doses according to their pre-existing Vitamin D level in addition to levothyroxine. Researchers will compare them with another group receiving only levothyroxine to see how much lipids improve in them

Timeline

Start
2024-03-01
Primary completion
2025-01-01
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 2000 iu
Background Levothyroxine Other / unclassified 1.6 ug/kg